0.9 C
New York
Sunday, November 28, 2021

OptiNose Inc. (OPTN) Stock Surges Following Upcoming Presentation at Cantor Global Healthcare Conference

OptiNose Inc. (OPTN) stock prices were down by 1.08% as of the market closing on September 22nd, 2021. This brought the price per share down to USD$2.75 at the end of the trading day. Subsequent premarket fluctuations saw the stock surge by 7.27%, bringing it up to USD$2.95.

OPTN Stock’s Presentation

September 22nd, 2021 saw OPTN stock announce the provision of a company overview and business update. CEO Peter Miller will present at the Cantor Virtual Global Healthcare Conference on September 28th, 2021. A live stream of the webcast will be available on the Investors page on the company’s website. A replay of the webcast will also be available for 30 days after the conclusion of the event.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


OPTN Stock’s Net Revenue

OPTN stock reported having generated USD$18.4 million in net revenue. The revenue was derived from sales of XHANCE for the three-month period ended June 30th, 2021. The six month period ended June 30th 2021 saw the company report USD$29.3 million in net revenue. Net revenues from the sales of XHANCE were up 79% for the three month period as compared to the prior year time period. The six month period reported a 69% year over year increase as compared to the six-month period ended June 30th, 2020.

R&D and SG&A Costs

The three month period ended June 30th, 2021 saw the company report research and development costs in the amount of USD$8.2 million. The first half of fiscal 2021 reported research and development costs in the amount of USD$13.4 million. Selling, general and administrative costs were reported at USD$27.3 million for the second quarter of fiscal 2021. The first half of fiscal 2021 saw OPTN stock report USD$54.5 million in SG&A costs.

Additional Financials

OPTN reported a net loss in the amount of USD$23.5 million for the three month period ended June 30th, 2021. This represents a net loss of USD$0.44 per both basic and diluted shares. The six month period ended June 30th, 2021 saw the company announce a USD$49.6 million net loss. This represents a net loss of USD$0.93 per both basic and diluted shares. The company reported a strong liquidity position in the amount of USD$93.9 million as of June 30th, 2021.

Future Outlook for OPTN Stock

The company reported a promising quarter, as evidenced by the strength of its financial reports for the first half of fiscal 2021. OPTN stock is poised to capitalize on the opportunities at its disposal as it continues expanding its reach. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is believed to result in sustained and significant increases in shareholder value over the long term.

Related Videos

Latest news

Related news

Related Videos

LEAVE A REPLY

Please enter your comment!
Please enter your name here

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

644

100% free. stop anytime no spam